We have previously shown that cellular retinoic acidbinding protein II (CRABP-II), but not cellular retinoic acid -binding protein I (CRABP-I), mRNA expression is markedly induced in human skin by topical retinoic acid. In the present study, we have investigated the pattern of expression of CRABP-II transcripts in 4-d RA-treated human skin by non-radioactive in situ hybridization (n = 5) and Northern analysis (n = 4) . RA induced accumulation of CRABP-II transcripts throughout the epidermis, dermal fibroblasts, and endothelial cells as determined by in situ hybridization. In skin treated with vehicle, a faint hybridization signal was observed only in basal layers of the epidermis consistent with low-level expression of CRABP-II mRNA. RA-mediated accumulation of CRABP-II transcripts in skin was also c~n firmed by Northern analysis . Neither RA nor vehicle tnduced significant changes in nuclear RA receptor-yl or keratin 5 gene expression in skin as determined by in situ . or Northern hybridization. These results indicate that RA-tnduced CRABP-II mRNA accumulation is primarily localiz~d to spinous and granular layers in epidermis, and in superficial dermis. ] Invest Dermatol 99: 146 -150, 1992 ---------------------------------------------------------------------------------------------------------R etinoic acid (RA), a vitamin A derivative, is essential for epithelial cell organization and function [1, 2] . RA interacts with two families of intracellular binding proteins. One class of binding protein includes the nuclear retinoic acid receftor (RAR) family, which is composed of RAR-a, -p, and -y [3 -6 . At least seven isoforms of RAR-y have been identified, of which RAR-y1 mRNA appears to be the rredominant RAR-y isoform expressed at high levels in mouse [7] and human skin [8] . RA also interacts with a family of low -molecular-weight cytosolic binding proteins known as cellular retinoic acid -binding proteins (CRABP) [9, 10] . CRABP protein levels are elevated in psoriatic lesions and in retinoid-treated skin [8, 11, 12] in vivo, suggesting that it may playa role in mediating cutaneous retinoid effects.
To better understand the effects of RA in human skin, we have recently cloned eDNA for both human CRABP-I and CRABP-II [13] . Using Northern analysis, we previously demonstrated thaJ topical application of 0.1 % RA cream for 4 d produced marke induction of CRABP-I1 but not CRABP-I transcripts in keratome specimens in vivo [8] . . Recently, a sensitive, non-radioactive in situ hybridizatiOn method based on the use of digoxigenin-11-UTP analog has been developed for localization of specific RNA transcripts [14] . By eXamining expression of several messenger RNA, we have derno~ strated that this method is useful for detection of RNA transcripts In human skin. Using this technique, we report here the cell and tissue localization of CRABP-II, RAR-y1, and keratin 5 transcripts !O human skin following 4-d topical application of RA.
MATERIALS AND METHODS
Tissue Preparation Healthy human volunteers were treated on separate areas of the buttocks (9 X 3 em) with a single dose of approximately 500 mg 0.1 % RA cream (Retin A) or its vehicle (Orth d Pharmaceutical Corp., Raritan, NJ) which were maintained for ~ under occlusion prior to biopsy [13] . After obtaining written !IIformed consent, keratome biopsies and 4-mm punch biopsies were procured from the treated areas using 1 % lidocaine as a local anesthetic as previously described [15] . All protocols for human subj~ctS were approved by the University of Michigan Institutional Revle~ Board. For in situ hybridization, full-thickness biopsies (n "'" d were obtained by 4-mm punch, fixed in 4% paraformaldehY e (PFA) in 0.1 M sodium phosphate, pH 7.4, for 2 h, and cryopr o ' tected in 30% sucrose solution for at least 3 h. The fixed tissue was embedded in OCT (Lab-Tek, Naperville, IL) , sectioned at 5 J.l~ onto poly-L-lysine coated slides, and stored at -70°C. For North ern analyses, 0.2-mm-thick epidermal keratomes (n = 4) were snap-frozen in liquid nitrogen and stored until use.
eDNA Cloning, Plasmid Preparation, and Northern Analy' sis The human CRABP-II eDNA was isolated by polyrnerase chain reaction (PCR) amplification directly from human skin uSing 0022-202X/92/S05.00 Copyright © 1992 by The Society for Investigative Dermatology, Inc. two degenerate oligonucleotide primers to the deduced amino acid sequences 6 to 130 of mouse CRABP-II [10] .
Forward primer:
The 373-bp PCR fragment corresponding to CRABP-II was coned mto pGEM3Z plasmid (Promega Inc., Madison WI), seuenced, and found to be identical to the previously published w~tnan .CRABP-II sequence [13] . Isoform-specific RAR-yl probe b s a gift from professor Pierre Chambon, CNRS-LGME, Stras-R;~g, that was generated by subcloning of nucleotides 25 -586 of k' d -y1 sequence [7] . The cDNA clone for keratin 5 (K5) was a hybridized excess cRNA probe was removed by incubation of the sections with 200 f1g/ml ribonuclease A (RNase A) for 10 min at 37"C.
Immunohistochemical Detection RNA hybrids were detected by a procedure similar to that described by the manufacturer (Boehringer Mannheim Biochemicals), with some modification. Briefly, slides incubated with DIG-labeled probes were rinsed at room temperature in 100 mM Tris-HCI, pH 7.4,150 mM NaCL, 0.2% T~een-20 (TNE) for 5 min. Anti-DIG antibody coupled to horseradish peroXidase at 3 -7 U / ml was added and slides were incu~ated in a h';lmid chamber f?r 45 min at 37"C, followed by addition of peroXidase substrate, 3 -amino-9-ethylcarbazole, 0.05% wt/vol in acetate buffer, and H 2 0 2 at a final concentration of 0.01 % . . The chro~ogenic reaction was stopped by rinsing in PBS for 5 mm. The shdes were then mounted and viewed by light microscopy.
Control Experiments Several controls were included to monitor the specificity of reactions. For non-specific hybridization to mRNA, epidermal sections were pretreated with RNase A (200 f1g/ml) for 20 min at 37"C and then processed as described above.
In some experiments, the DIG-labeled probes or anti-DIG antibodies were omitted to rule out non-specific staining. Finally, sense nboprobes for C~P-II, RAR-yl, and K5 were separately hybrid-Ized to several sectIOns to ascertain probe specificity and background hybridization.
RESULTS
Modulation of CRABP-II, RAR-y1, and K5 Gene Expression in RA-Treated Skin To examine the effects of RA on gene expression at the mRNA level, [ 32 P]-labeled CRABP-II, RAR-yl, and K5 probes were hybridized to Northern blots ofRA and vehicle-treated skin (n = 4). Four-day treatment of skin with RA but not vehicle cream, under occlusion, resulted in a substantial induction of 1.3.-kb CRABP-II mRNA levels (Fig lA) . In contrast, topical applic.atlOn of RA did not affect RAR-yl or K5 mRNA expression relative to the vehicle control (Fig IB, C) . The size of mRNA for ~R-yl and ~5 in skin wa~ estimated at 3. confirmed by W estern blotting of RNA transcripts. Incubation of anti-DIG antibodies with filters containing both sense and antisense riboprobes, followed by the addition of peroxidase substrate, resulted in detection of single RNA bands ranging from a pink to light red color caused by the chromogenic reaction (Fig 2A -D) . Regardless of orientation of RNA synthesis, antisense and sense RNA transcripts for both CRABP-II and RAR-yl were intact as determined by their identical size on agarose gels (Fig 2A, B) . Moreover, comparison of the size of these cRNA probes with the known size of a control RNA marker supplied by the Boehringer Mannheim Biochemicals (BMB in Fig 2D) indicated that the use of DIG-modified nucleotides in in vitro transcription assays did not cause premature chain termination of riboprobes. Prior to gel electrophoresis, the K5 cRNA probe shown in Fig 2C was hydrolyzed to produce probes of 200 -600 nucleotides [17] and thus it appears as a smear on gels.
Cell and Tissue Localization ofKS, RAR-y1, and CRABP-II Transcripts We first examined the distribution of K5 mRNA in skin by in situ hybridization before proceeding with those mRNA whose location in RA-treated human skin had not been previously determined . Using the K5 antisense riboprobe, a strong signal was detected in both 4-d vehicle and RA-treated epidermal sections (n = 5), which was localized predominantly to basal cells (Fig 3A,  B) , consistent with a previous report [18] . Pretreatment of epidermal sections with RNase A (Fig 3C) or hybridization of sections with the sense riboprobe ( Fig 3D) markedly diminished the K5 hybridization signal.
In vehicle-treated skin, CRABP-II mRNA was not induced, although a faint hybridization signal was seen in basal layers of epider-THE JOURNAL OF INVESTIGATIVE DERMATOLOGY mis ( Fig 4A) . In contrast, 4 d of RA treatment greatly increased CRAEP-II transcripts, particularly in basal and suprabasal layers ( Fig 4B) . In RA-treated skin, intracellular staining was observed throughout epidermis with a clear distribution of signals towards the upper pole of keratinocytes. Hybridization signal was also detected in some but not all nuclei of cells. Of particular interest was the extensive staining and localization of CRAEP-II RNA transcripts in spinous and granular layers in RA as compared to vehicletreated skin (arrowheads in Fig 4A, B) . Specificity of reactions was demonstrated by pretreatment with RNase A intended to degrade endogenous skin mRNA, and hybridization of RA-treated epidermal sections with CRAEP-II sense probe. These controls were negative in all instances and produced minimal background (Fig 4C, D) .
Increased CRAEP-II transcripts were also observed as strong hybridization signal in superficial dermis within endothelial cells and cells with fibroblast-like morphology (Fig 4B) . Examination of these sections by light microscopy under higher magnification revealed that hybridization signals were localized to spindle-shaped fibr~ blasts (magnification X 250, Fig SA) and endothelial cells (magnification X 100, Fig 5B) .
In situ hybridization with the RAR-yl antisense probe revealed a uniform distribution of mRNA transcripts in epidermis. In vehicletreated skin, hybridization signal was mainly cytoplasmic in epidermal and dermal cells ( Fig 6A) . An analogous pattern of expreSSIOn was also observed in RA-treated skin ( Fig 6B) with no signific~nt differences in signal intensity between RA and vehicle-treated skin. As before, hybridization of RNase pretreated sections with the antisense probe, or the use of a sense RAR-yl probe, exhibited no sign~fi cant staining (Fig 6C, D) , demonstrating the specificity of in SitU hybridization.
DISCUSSION
Previous work has shown that total CRAEP activity in skin is induced by both topical and systemic administration of natural and synthetic retinoids [12, 19] . By cloning cDNA for two hurn~n CRABP isoforms, CRAEP-I and CRAEP-II and Northern analYSIS, we have recently demonstrated that CRAEP-II, but not CRABP-I transcripts, are markedly induced by topical RA treatment in whole keratome biopsies in vivo [13] . In this report, we have extended ?ur findings by examining the pattern of CRAEP-II mRNA expreSSion in RA-treated skin using non-radioactive in situ hybridization. I
We have preVIOusly reported that although epidermal CRABP-I mRNA is markedly elevated by RA in vivo, it is not induced In B f t t t -.
. \L 8 . monolayer cultures of human keratinocytes in vitro [13] . In situ hybridization reveals that the increased CRABP-Il mRNA seen in whole epidermal biopsies [13] is derived not only from keratinocytes in the epidermis, but also from dermal fibroblasts as well as endothelial cells in superficial dermis. Thus, these findings imply that a stratified epidermis and/or the presence of dermis may be important determinants for induction of CRABP-Il mRNA expression by RA in skin in vivo. CRABP-I mRNA is normally undetectab le in normal adult human skin, as has been recently shown by in situ hybridization [20] and Northern analysis [8] , and it is not increased by RA in skin as we have previously demonstrated [13] . Thus, the upregulation of CRABP-Il transcripts by RA seen here is independent and unrelated to changes in CRABP-I mRNA levels. Moreover, the faint hybridization signal observed by in situ hybridization in basal keratinocytes in vehicle-treated skin is presumably the result of low level presence of CRABP-Il mRNA, consistent with our Northern analysis. These results are compatible with the recent findings that increased CRABP-Il, but not CRABP-I transcripts, are responsible also for elevated CRABP mRNA levels in psoriatic skin [8, 20] . The marked increased in hybridization signal in cells in spinous and granular layers of epidermis in response to RA indicates an increase in steady-state CRABP-I1 mRNA levels in differentiated keratinocytes. If an elevated mRNA level reflects a relative increase in functional protein expression, one can speculate that CRABP-I1 is an active participant in the cellular response to RA in human skin. In F9 teratocarcinoma cells, overexpression of CRABP-I appears to limit the differentiating effects of RA [21] . It remains to be determined whether or not induction of CRABP-I1 mRNA by RA in spinous and granular layers, as demonstrated by in situ hybridization, serves a similar purpose.
No significant changes in RAR-y1 transcript levels were seen in either RA or vehicle-treated skin by in situ hybridization or Northern analysis. Because previous Northern analyses have also demonstrated insignificant changes in RAR-y1 mRNA levels in skin in response to RA [8] , our current in situ data provide additional support that RAR-y1 mRNA is not increased by RA in skin. Presence of predominantly cytoplasmic staining for RAR-y1 may reflect the steady-state transcript levels and argue against a high rate of RARyl mRNA turnover. Our in situ studies further indicate that RA, when applied topically does not alter the pattern of expression ofKS mRNA in human skin. Keratin S and keratin 14 are two keratin pairs whose mRNA are coordinately regulated and uniquely expressed in basal cells in normal skin [1 8 ]. These res ults are consistent with a previous report that RA does not alter basal cell expression of immunostained keratin 14 in vivo [22] .
In conclusion, we have utilized a digoxigenin-labeled CRABP-II riboprobe to study cell and tissue expression of CRABP-II mRNA in 4-d RA-treated human skin. We have demonstrated that CRABP-II transcripts accumulated in the epidermis and superficial dermis in response to RA. No significant changes occurred in either RAR-y1 or keratin 5 mRNA levels as determined by in situ hybridization and Northern analysis.
